Evidence map›Paper›PMID 29465544›Full record

ArticleMedicine2018

The choose of different surgical therapies of hepatic alveolar echinococcosis: A single-center retrospective case-control study.

Ke-Fei Chen, You-Yin Tang, Rui Wang, Dan Fang, Jun-Hua Chen, Yong Zeng, Bo Li, Tian-Fu Wen, Wen-Tao Wang, Hong Wu and 9 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Current status and future prospects ofVeterinary and animal science · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prediction and identification of epitopes in the Echinococcus multilocularis thrombospondin 3 antigen.Technology and health care : official journal of the European Society for Engineering and Medicine · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Ke-Fei ChenDepartment of Liver Surgery, Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu Institute of hydatid disease prevention and control, Ganze prefecture, Sichuan Province, China Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
You-Yin Tang
Rui Wang
Dan Fang
Jun-Hua Chen
Yong Zeng
Bo Li
Tian-Fu Wen
Wen-Tao Wang
Hong Wu
Ming-Qing Xu
Jia-Yin Yang
Yong-Gang Wei
Ji-Wei Huang
Jia-Xin Li
Han-Zhi Zhang
Xi Feng
Lü-Nan Yan
Zhe-Yu Chen
West China Hospital of Sichuan University · CNSichuan University · CNMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The aim of this study was to evaluate different surgical therapies for hepatic alveolar echinococcosis in different clinical stages.We analyze the clinical data of 115 patients who received surgical treatment in West China Hospital from January 2004 to June 2016. Among these patients, 77 cases underwent radical hepatic resection (group A, n = 77); 17 cases underwent palliative resection (group B, n = 17), and 21 cases underwent liver transplantation (group C, n = 21) with 12 cases of orthotopic liver transplantation and 9 cases of liver autotransplantation.The postoperative complication rate of radical hepatic resection group was 13.0% (10/77), which is statistically significant (P < .05) than the rate of palliative resection group 29.4% (5/17) or liver transplantation group 23.8% (5/21). The follow-up period ranged from 1 to 72 months. The overall median survival rate of radical resection was 72/77, higher than the rate of palliative group (12/17) or transplantation group (17/21), which was also statistically significant (P < .01).In our study, we believe in that all stages of hepatic alveolar echinococcosis should take active surgical interventions, and radical hepatic resection should be considered as the first-choice treatment for early stage of alveolar echinococcosis, while palliative surgery is still helpful to relieve symptoms and improve the life quality for advanced patients. Liver transplantation might also be an alternative option for the late-stage hepatic alveolar echinococcosis.

Indexed as

AdolescentAdultAgedAged, 80 and overCase-Control StudiesChildEchinococcosis, HepaticFemaleHepatectomyHumansLiver TransplantationMaleMiddle AgedPalliative CarePostoperative ComplicationsRetrospective Studies

Identifiers

PMID29465544
PMCPMC5841995
OpenAlexW2789510159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.